gabexate has been researched along with evans blue in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antoniu, BA; Balcom, JH; Fernández-del Castillo, CF; Keck, T; Lewandrowski, K; Warshaw, AL | 1 |
Aki, K; Goromaru, T; Ito, Y; Itoh, Y; Mori, S; Nishibori, M; Oike, M; Oishi, R; Sendo, T; Sumimura, T; Yano, T | 1 |
2 other study(ies) available for gabexate and evans blue
Article | Year |
---|---|
Regional effects of nafamostat, a novel potent protease and complement inhibitor, on severe necrotizing pancreatitis.
Topics: Animals; Benzamidines; Capillary Permeability; Complement Inactivator Proteins; Evans Blue; Gabexate; Guanidines; Injections, Intra-Arterial; Injections, Intravenous; Lung; Male; Oligopeptides; Pancreas; Pancreatitis, Acute Necrotizing; Peritoneum; Peroxidase; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Serine Proteinase Inhibitors; Survival Rate | 2001 |
Involvement of proteinase-activated receptor-2 in mast cell tryptase-induced barrier dysfunction in bovine aortic endothelial cells.
Topics: Actins; Anaphylaxis; Animals; Antigens, CD; Aorta; Benzamidines; Cadherins; Calcium Signaling; Capillary Permeability; Cattle; Cells, Cultured; Contrast Media; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Inhibitors; Evans Blue; Gabexate; Guanidines; Ioxaglic Acid; Receptor, PAR-2; Serine Endopeptidases; Stress Fibers; Tryptases | 2003 |